HOME >> BIOLOGY >> NEWS
Study Affirms Value Of Non-Surgical Treatment For Arrhythmia

A widely used nonsurgical treatment for rapid heart rhythms is safe and beneficial for both children and adults, according to results of a national study led by Johns Hopkins physicians.

"This is the first large multicenter study to suggest that radiofrequency catheter ablation is safe and effective therapy, and that it can now be considered as an alternative to drug therapy in the treatment of certain cardiac arrhythmias," says Hugh Calkins, M.D., lead author of the study and director of electrophysiology at Hopkins. "Before this procedure was developed in the early 1990s, arrhythmia patients were treated with medication, underwent open heart surgery or suffered. The technology has now advanced to the point at which we can do the procedure on an outpatient basis, curing patients within a matter of hours and sending them home the same day."

Radiofrequency catheter ablation destroys parts of the electrical pathways in the heart that cause rapid heart rhythms, or arrhythmias. A physician guides a catheter with an electrode at the tip to the focal point of the abnormal pathway in the heart muscle. Then a mild, painless burst of energy -- similar to microwave heat -- is transmitted to destroy the small area of heart tissue containing the pathway, ending the electrical misfirings that caused the arrhythmia.

Calkins estimates that more than 15,000 catheter ablations are performed nationwide each year. About one in every 100 people has some type of arrhythmia.

Results of the study were published in the Jan. 19 issue of Circulation, an American Heart Association journal.

Researchers followed 1,050 patients who underwent three types of catheter ablations between 1992 and 1995. The patient population consisted of 439 males and 561 females ranging in age from eight months to 90 years. Among the group, 133 (13 percent) were younger than 13 and 193 (18 percent) were between 13 and 20 years ol
'"/>

Contact: Brian Vastag
bvastag@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
19-Jan-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment ... in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with ... Check local listings for more info. , Today, the majority of testing is performed ... throughout the country. Results are then available several days later. Now, in an effort ...
(Date:6/23/2020)... Texas (PRWEB) , ... June 23, 2020 , ... ... analytical instrumentation, is pleased to announce the next event in a series of ... scattering. , The TOPIQ series of webinars was developed in response to social ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... , ... July 16, 2020 , ... “We are thrilled ... Wave Bioactives. “It’s the only technology of its kind on the market and we ... onions with the protective capacity of traditional cultured ingredients, creating a natural way to ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... for the life sciences and food industries, is pleased to announce that Charles ... Research – Business Development. , Charles is an accomplished and results-driven sales executive ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., ... hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of ...
Breaking Biology Technology:
Cached News: